| Issue |
Med Sci (Paris)
Volume 33, Number 8-9, Août–Septembre 2017
|
|
|---|---|---|
| Page(s) | 691 - 694 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/20173308002 | |
| Published online | 18 September 2017 | |
La chimiokine CXCL12 et son récepteur CXCR4 dans le contrôle des infections par les papillomavirus humains
Nouveaux facteurs de susceptibilité à la pathogénie virale
The CXCL12/CXCR4 signaling pathway in the control of human papillomavirus infection: new susceptibility factors in viral pathogenesis
1
Inflammation, chimiokines et immunopathologie, Inserm UMR 996, Fac. de médecine-Univ Paris-Sud, Université Paris-Saclay, Clamart, France
2
US31-UMS3679, Plateforme PHIC, Institut Paris-Saclay d’Innovation Thérapeutique (IPSIT), Inserm, CNRS, Univ Paris-Sud, Université Paris-Saclay, Clamart, France
*
francoise.bachelerie@u-psud.fr
Cet article ne possède pas de résumé.
© 2017 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
